Institutional Review Board

Policies and Procedures

NOTE: The policies below are being updated on an ongoing basis. In the meantime, references to "Committee on Clinical Investigations," "CCI," or "MMC IRB" refer to the Einstein IRB. New and recently revised policies have "Revision" dates highlighted in yellow. 

 

See also: Institutional Research Policies 

 

Revision Date  Policy 

3/10/05
7/8/11
3/14/02		 Categories of Research
  - Research Eligible for Exemption
  - Research Eligible for Expedited Review
  - Research Requiring Full Board Review 
2/5/10 Principal Investigator Requirements 
5/07 Research Record Retention Policy 
2/07 Participation of Research Personnel as Research Subjects Policy 
9/7/04 Protocol Deviation Policy and Procedure 
3/07 Data and Safety Monitoring Policy 
7/12/02 Research Involving Psychiatric In-Patients 
12/17/12 Amendment Policy and Procedure 
3/7/12 Policy on Disclosing Financial Conflicts of Interest to the Einstein IRB 
2/13/12 Informed Consent Guidelines 
1/12/01 Policy and Procedure for Reporting Protocol Non-Compliance 
1/13/12 Required Documentation for the Conduct of Research Involving Human Subjects 
5/21/07 Collection and/or Study of Human Specimens Policy 
5/8/03 Investigational Drug, Biologic and Device Policy 
5/8/03 Emergency Use of an Investigational Drug or Biologic Policy and Procedure 
5/8/03 Emergency Use of an Investigational Device Policy and Procedure 
10/12/04 Guidelines for Storage and Dispensing of Investigational Drugs 
3/01 Compensation Language Policy 
5/12/05 Radiation/Radioisotope Guidelines 
2/08 Non-Pregnant Women Research Policy 
2/20/13 HIV Guidelines 
7/8/11 Fetal Tissue Research Policy 
2/8/07 Pregnant Women or Fetuses Research Policy 
1/24/05 Enrollment of Subjects in Significant Pain 
12/6/11 Guidelines for the Recording of Research Subjects 
1/08 Transportation of Subjects 
9/18/02 Advertisement Policy 
12/15/11 Guidelines for Compensation of Research Subjects 
10/23/09 Inclusion of Children in NIH Research Protocols 
10/23/09 NIH Regulations Regarding FDA Correspondence 
2/01 Committee Jurisdiction Policy AECOM/MMC 
5/8/03 Enrollment of Minors in Research – Principles and Guidelines 
10/11/07 Internal Adverse Event Policy 
9/07 External Adverse Event Policy 
6/19/03 Policy for the Use of Patient Medical Record Information in Research and Recruitment of Research Participants 
12/6/11 Yeshiva University Undergraduate Student and Faculty Research Guidelines 
2/5/10 Policy for Informing Research Participants of Protocol Amendments and/or New Risk Information 
8/5/05 Placebo-Use and Washout in Psychiatric Research 
1/31/11 Policy and Procedure for National Cancer Institute CIRB 
1/14/11 Cell Line and Dataset Policy 
1/24/08 Registration of Clinical Trials 
1/13/12 Audit and Inspection Guidelines 
2/4/13  Case Report Policy (Authorization Form)
Click here to log in